enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Low RSV and COVID vaccine usage is in line with investor ...

    www.aol.com/finance/low-rsv-covid-vaccine-usage...

    It now expects revenue in the range of $59.5 billion to $62.5 billion, up from $58.5 billion to $61.5 billion — with a combined $8.5 billion expected from the COVID vaccine and COVID treatment ...

  3. Moderna president: Company outlook 'stabilizing' thanks to ...

    www.aol.com/finance/moderna-president-company...

    The respiratory vaccines are priced lower than other vaccines, like Merck's HPV vaccine, Gardasil, which has a list price of $300 or more. (List price for Moderna's COVID vaccine: $110.) (List ...

  4. COVID-19 vaccination in the United States - Wikipedia

    en.wikipedia.org/wiki/COVID-19_vaccination_in...

    The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States. The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, [ 7 ] and mass vaccinations began four days later. The Moderna ...

  5. Deployment of COVID-19 vaccines - Wikipedia

    en.wikipedia.org/.../Deployment_of_COVID-19_vaccines

    The facility set a goal of supplying COVID‑19 vaccines to nearly 100 low-to-middle income countries that could not afford them. COVAX sought to fundraise US$6.8 billion to purchase and deliver vaccines to participating countries in proportion to their populations. [ 32 ]

  6. Is it time to buy the beaten-down stock? - AOL

    www.aol.com/finance/down-more-50-time-buy...

    Moderna's COVID vaccine sales have fallen off a cliff, with a revenue of just $241 million in the second quarter, down 30% from $344 million a year ago. It had $19.3 billion in total revenue for ...

  7. Moderna COVID-19 vaccine - Wikipedia

    en.wikipedia.org/wiki/Moderna_COVID-19_vaccine

    The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA). Depending on the jurisdiction, it is authorized for use in ...

  8. Moderna forecasts lower sales next year, shares near four ...

    www.aol.com/news/moderna-expects-3-5-billion...

    Shares of the vaccine maker tumbled 17.1% to $65.88 at midday. The company expects sales between $2.5 billion and $3.5 billion in 2025, below analysts' forecast of $3.74 billion, according to LSEG ...

  9. History of COVID-19 vaccine development - Wikipedia

    en.wikipedia.org/wiki/History_of_COVID-19...

    Contents. History of COVID-19 vaccine development. Scientifically accurate atomic model of the external structure of SARS-CoV-2. Each "ball" is an atom. SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), the virus that causes COVID-19, was isolated in late 2019. [ 1 ] Its genetic sequence was published on 11 January 2020, triggering ...